Basics |
AIM ImmunoTech Inc. |
IPO Date: |
August 1, 1996 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$6.52M |
Activated in VL: |
False |
Average Daily Range |
Avg Daily Range: |
$0.11 | 3.46%
|
Avg Daily Range (30 D): |
$0.01 | 6.13%
|
Avg Daily Range (90 D): |
$0.01 | 5.34%
|
Institutional Daily Volume |
Avg Daily Volume: |
.31M |
Avg Daily Volume (30 D): |
.33M |
Avg Daily Volume (90 D): |
.73M |
Trade Size |
Avg Trade Size (Sh.): |
413 |
Avg Trade Size (Sh.) (30 D): |
872 |
Avg Trade Size (Sh.) (90 D): |
971 |
Institutional Trades |
Total Inst.Trades: |
20 |
Avg Inst. Trade: |
$1.17M |
Avg Inst. Trade (30 D): |
$M |
Avg Inst. Trade (90 D): |
$M |
Avg Inst. Trade Volume: |
.41M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$.79M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
312.22K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-.31
|
$-.1
|
$-.31
|
Diluted EPS
|
$-.31
|
$-.1
|
$-.31
|
Revenue
|
$ .17M
|
$ .05M
|
$ .17M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -17.32M
|
$ -5.97M
|
$ -17.32M
|
Operating Income / Loss
|
$ -19.77M
|
$ -5.86M
|
$ -19.77M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -3.74M
|
$ .79M
|
$ -3.74M
|
PE Ratio
|
|
|
|
|